SCHEMBL7476034

SCHEMBL7476034

O=C(C[C@H](CCCc1ccccc1)C(=O)O)c1ccc2c3c(oc2c1)CCC3

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 1/20 0.41
MMP2 P08253 1/20 0.41
MMP3 P08254 1/20 0.41
MMP9 P14780 1/20 0.41
MMP8 P22894 1/20 0.41
GRIK1 P39086 1/20 0.40
KMO O15229 1/20 0.39
L3MBTL1 Q9Y468 3/20 0.39
ALDH1A1 P00352 2/20 0.39
KDM4E B2RXH2 1/20 0.39
GAA P10253 1/20 0.39
HPGD P15428 1/20 0.39
HSD17B10 Q99714 1/20 0.39
TDP1 Q9NUW8 4/20 0.39
NFKB1 P19838 2/20 0.39
MAOB P27338 2/20 0.39
LMNA P02545 1/20 0.36
TP53 P04637 1/20 0.36
MAPT P10636 1/20 0.36
KLF5 Q13887 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7485610 1.00 MMP1 (0.41) MMP1MMP2MMP3MMP9MMP8
SCHEMBL7429273 0.98 MMP1 (0.41) MMP1MMP2MMP3MMP9MMP8
SCHEMBL7430672 0.97 MMP1 (0.41) MMP1MMP2MMP3MMP9MMP8
SCHEMBL7424360 0.97 MMP1 (0.41) MMP1MMP2MMP3MMP9MMP8
SCHEMBL7487181 0.97 KMO (0.39) MMP1MMP2MMP3MMP9MMP8
SCHEMBL7484254 0.97 KMO (0.39) MMP1MMP2MMP3MMP9MMP8
SCHEMBL7482509 0.96 KMO (0.38) MMP1MMP2MMP3MMP9MMP8
SCHEMBL7484654 0.96 KMO (0.38) MMP1MMP2MMP3MMP9MMP8
SCHEMBL7488807 0.96 KMO (0.38) MMP1MMP2MMP3MMP9MMP8
SCHEMBL7484209 0.96 KMO (0.38) MMP1MMP2MMP3MMP9MMP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2000006560-A1 TRICYCLIC HETEROAROMATICS AND THEIR DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES WARNER-LAMBERT COMPANY (US) 2000-02-10 WO claimed
US-6350885-B1 TREATMENT OF MULTIPLE SCLEROSIS, ATHEROSCLEROTIC PLAQUE RUPTURE, AORTIC ANEURYSM, HEART FAILURE, LEFT VENTRICULAR DILATION, RESTENOSIS, PERIODONTAL DISEASE, CORNEAL ULCERATION, TREATMENT OF BURNS, DECUBITAL ULCERS, WOUND HEALING AGENT WARNER-LAMBERT COMPANY 2002-02-26 US disclosed
WO-2000006560-A1 TRICYCLIC HETEROAROMATICS AND THEIR DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES WARNER-LAMBERT COMPANY (US) 2000-02-10 WO disclosed